Feasibility of WHO mhGAP-intervention guide in reducing experienced discrimination in people with mental disorders: a pilot study in a rural Kenyan setting.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7960
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 5 6 2018
medline: 13 9 2019
entrez: 5 6 2018
Statut: ppublish

Résumé

AimsStigma can have a negative impact on help-seeking behaviour, treatment adherence and recovery of people with mental disorders. This study aimed to determine the feasibility of the WHO Mental Health Treatment Gap Interventions Guidelines (mhGAP-IG) to reduce stigma in face-to-face contacts during interventions for specific DSM-IV/ICD 10 diagnoses over a 6-month period. This study was conducted in 20 health facilities across Makueni County in southeast Kenya which has one of the poorest economies in the country and has no psychiatrist or clinical psychologist. We recruited 2305 participants from the health facilities catchment areas that had already been exposed to community mental health services. We measured stigma using DISC-12 at baseline, followed by training to the health professionals on intervention using the WHO mhGAP-IG and then conducted a follow-up DISC-12 assessment after 6 months. Proper management of the patients by the trained professionals would contribute to the reduction of stigma in the patients. There was 59.5% follow-up at 6 months. Overall, there was a significant decline in 'reported/experienced discrimination' following the interventions. A multivariate linear mixed model regression indicated that better outcomes of 'unfair treatment' scores were associated with: being married, low education, being young, being self-employed, higher wealth index and being diagnosed with depression. For 'stopping self' domain, better outcomes were associated with being female, married, employed, young, lower wealth index and a depression diagnosis. In regards to 'overcoming stigma' domain; being male, being educated, employed, higher wealth index and being diagnosed with depression was associated with better outcomes. The statistically significant (p < 0.05) reduction of discrimination following the interventions by trained health professionals suggest that the mhGAP-IG may be a useful tool for reduction of discrimination in rural settings in low-income countries.

Identifiants

pubmed: 29862937
pii: S2045796018000264
doi: 10.1017/S2045796018000264
pmc: PMC6999029
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-167

Subventions

Organisme : Medical Research Council
ID : MR/R023697/1
Pays : United Kingdom

Références

Lancet. 2016 Mar 12;387(10023):1123-1132
pubmed: 26410341
Soc Sci Med. 2014 Dec;123:149-59
pubmed: 25462616
Soc Psychiatry Psychiatr Epidemiol. 2016 Jan;51(1):73-80
pubmed: 26154242
BMC Psychiatry. 2010 Dec 30;10:113
pubmed: 21192795
Aust N Z J Psychiatry. 2006 Jan;40(1):51-4
pubmed: 16403038
AIDS Behav. 2012 Nov;16(8):2101-18
pubmed: 22116638
Front Hum Neurosci. 2014 Jan 24;8:6
pubmed: 24478672
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
J Affect Disord. 2016 Oct;203:121-129
pubmed: 27285725
Psychiatr Serv. 2001 Dec;52(12):1627-32
pubmed: 11726754
Lancet. 2009 Jan 31;373(9661):408-15
pubmed: 19162314
Int J Soc Psychiatry. 2018 Mar;64(2):120-129
pubmed: 29258407
J Gerontol A Biol Sci Med Sci. 2001 Oct;56 Spec No 2:23-35
pubmed: 11730235
Lancet. 2017 Mar 4;389(10072):951-963
pubmed: 28271846
BMC Psychiatry. 2012 Nov 01;12:187
pubmed: 23116126
Psychiatry Res. 2013 Jun 30;208(1):33-40
pubmed: 23582210
World Psychiatry. 2014 Jun;13(2):161-75
pubmed: 24890069
Soc Psychiatry Psychiatr Epidemiol. 2016 Mar;51(3):465-74
pubmed: 26498927
Psychiatr Serv. 2012 Oct;63(10):963-73
pubmed: 23032675
World Psychiatry. 2014 Jun;13(2):107-9
pubmed: 24890053

Auteurs

V N Mutiso (VN)

Africa Mental Health Foundation,Nairobi,Kenya.

K Pike (K)

Global Mental Health Program,Columbia University,New York,USA.

C W Musyimi (CW)

Africa Mental Health Foundation,Nairobi,Kenya.

T J Rebello (TJ)

Global Mental Health Program,Columbia University,New York,USA.

A Tele (A)

Africa Mental Health Foundation,Nairobi,Kenya.

I Gitonga (I)

Africa Mental Health Foundation,Nairobi,Kenya.

G Thornicroft (G)

Institute of Psychiatry, King's College London,London,UK.

D M Ndetei (DM)

Africa Mental Health Foundation,Nairobi,Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH